Status:
RECRUITING
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
Lead Sponsor:
Fudan University
Conditions:
Lung Adenocarcinoma
Frozen Section
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection ...
Eligibility Criteria
Inclusion
- Patients who sign the informed consent form and are willing to complete the study according to the plan;
- Aged from 18 to 80 years old;
- ECOG equals 0 or 1;
- Not receiving lung cancer surgery before;
- Resectable peripheral cT1N0M0 tumors;
- Single lung nodules with ground-glass dominant or pure ground-glass on CT, or multiple lung nodules with the major lesion being the aforementioned nodules;
- Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
- Not receiving chemotherapy or radiotherapy before.
Exclusion
- Not cT1N0M0;
- Cannot be completely resected by sublobar resection;
- Invasive lung adenocarcinoma or not lung adenocarcinoma diagnosed cytologically or pathologically;
- Receiving lung cancer surgery before;
- Receiving radiotherapy or chemotherapy.
Key Trial Info
Start Date :
March 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT06031181
Start Date
March 31 2023
End Date
December 31 2030
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Cancer Center
Shanghai, Shanghai Municipality, China, 200032